Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 1 to 20 of 68

1.

Health effects of nanomaterials.

Tetley TD.

Biochem Soc Trans. 2007 Jun;35(Pt 3):527-31. Review.

PMID:
17511644
2.

Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop.

Warheit DB, Borm PJ, Hennes C, Lademann J.

Inhal Toxicol. 2007 Jun;19(8):631-43.

PMID:
17510836
3.

Limits and prospects of the "incremental approach" and the European legislation on the management of risks related to nanomaterials.

Franco A, Hansen SF, Olsen SI, Butti L.

Regul Toxicol Pharmacol. 2007 Jul;48(2):171-83. Epub 2007 Apr 14.

PMID:
17509740
4.

Nanomedicine: techniques, potentials, and ethical implications.

Ebbesen M, Jensen TG.

J Biomed Biotechnol. 2006;2006(5):51516.

5.

Nucleation of protein fibrillation by nanoparticles.

Linse S, Cabaleiro-Lago C, Xue WF, Lynch I, Lindman S, Thulin E, Radford SE, Dawson KA.

Proc Natl Acad Sci U S A. 2007 May 22;104(21):8691-6. Epub 2007 May 7.

6.

In vitro and in vivo toxicity of CdTe nanoparticles.

Zhang Y, Chen W, Zhang J, Liu J, Chen G, Pope C.

J Nanosci Nanotechnol. 2007 Feb;7(2):497-503.

PMID:
17450785
7.

In-cabin commuter exposure to ultrafine particles on Los Angeles freeways.

Zhu Y, Eiguren-Fernandez A, Hinds WC, Miguel AH.

Environ Sci Technol. 2007 Apr 1;41(7):2138-45.

PMID:
17438754
8.

Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition.

Gojova A, Guo B, Kota RS, Rutledge JC, Kennedy IM, Barakat AI.

Environ Health Perspect. 2007 Mar;115(3):403-9. Epub 2006 Dec 11.

9.

Inhalation exposure study of titanium dioxide nanoparticles with a primary particle size of 2 to 5 nm.

Grassian VH, O'shaughnessy PT, Adamcakova-Dodd A, Pettibone JM, Thorne PS.

Environ Health Perspect. 2007 Mar;115(3):397-402. Epub 2006 Dec 4.

10.

Gene expression in nanotoxicology research: analysis by differential display in BALB3T3 fibroblasts exposed to cobalt particles and ions.

Papis E, Gornati R, Prati M, Ponti J, Sabbioni E, Bernardini G.

Toxicol Lett. 2007 May 15;170(3):185-92. Epub 2007 Mar 13.

PMID:
17412531
11.

The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area.

Monteiller C, Tran L, MacNee W, Faux S, Jones A, Miller B, Donaldson K.

Occup Environ Med. 2007 Sep;64(9):609-15. Epub 2007 Apr 4.

12.

Variables influencing interactions of untargeted quantum dot nanoparticles with skin cells and identification of biochemical modulators.

Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA.

Nano Lett. 2007 May;7(5):1344-8. Epub 2007 Apr 5.

PMID:
17408303
14.

Phytotoxicity of nanoparticles: inhibition of seed germination and root growth.

Lin D, Xing B.

Environ Pollut. 2007 Nov;150(2):243-50. Epub 2007 Mar 19.

PMID:
17374428
15.

A murine scavenger receptor MARCO recognizes polystyrene nanoparticles.

Kanno S, Furuyama A, Hirano S.

Toxicol Sci. 2007 Jun;97(2):398-406. Epub 2007 Mar 14.

PMID:
17361018
16.

Nanotechnology: a promising new technology--but how safe?

Priestly BG, Harford AJ, Sim MR.

Med J Aust. 2007 Feb 19;186(4):187-8.

PMID:
17309420
17.

Comparative toxicity of nano-scale TiO2, SiO2 and ZnO water suspensions.

Adams LK, Lyon DY, McIntosh A, Alvarez PJ.

Water Sci Technol. 2006;54(11-12):327-34.

PMID:
17302336
18.

Quantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells.

Choi AO, Cho SJ, Desbarats J, Lovrić J, Maysinger D.

J Nanobiotechnology. 2007 Feb 12;5:1.

19.

Nanomedicine and nanotoxicology: two sides of the same coin.

Kagan VE, Bayir H, Shvedova AA.

Nanomedicine. 2005 Dec;1(4):313-6. Review.

PMID:
17292104
20.

Nanotechnology and nanotoxicology: a primer for clinicians.

Curtis J, Greenberg M, Kester J, Phillips S, Krieger G.

Toxicol Rev. 2006;25(4):245-60. Review.

PMID:
17288496

Supplemental Content

Support Center